Capital World Investors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-398,294
Closed -$181M 544
2022
Q3
$181M Buy
398,294
+83
+0% +$39.7K 0.04% 280
2022
Q2
$192M Buy
398,211
+10,100
+3% +$5M 0.04% 278
2022
Q1
$191M Buy
+388,111
New +$177M 0.03% 302
2016
Q1
Sell
-1,840
Closed -$257K 498
2015
Q4
$257K Hold
1,840
﹤0.01% 517
2015
Q3
$258K Hold
1,840
﹤0.01% 516
2015
Q2
$302K Hold
1,840
﹤0.01% 525
2015
Q1
$284K Hold
1,840
﹤0.01% 521
2014
Q4
$231K Hold
1,840
﹤0.01% 526
2014
Q3
$220K Hold
1,840
﹤0.01% 515
2014
Q2
$198K Hold
1,840
﹤0.01% 514
2014
Q1
$183K Sell
1,840
-1,998,160
-100% -$181M ﹤0.01% 499
2013
Q4
$185M Sell
2,000,000
-2,000,000
-50% -$178M 0.05% 239
2013
Q3
$334M Hold
4,000,000
0.1% 193
2013
Q2
$327M Buy
+4,000,000
New +$299M 0.11% 188

Other funds holding ELV

Capital World Investors's ELV Position: Q4 2022 in Review

Capital World Investors sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 398,294 shares — an estimated $181M sold.

Capital World Investors first reported a position in ELV in Q2 2013 and held it in 14 quarters. The position peaked at $334M in Q3 2013. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Capital World Investors reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
  • Capital World Investors sold 398,294 Elevance Health shares in Q4 2022, an estimated $181M.
  • Capital World Investors first reported a position in Elevance Health in Q2 2013 and held it in 14 quarters.
  • Capital World Investors's Elevance Health position peaked at $334M in Q3 2013.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Capital World Investors's 13F filing for Q4 2022, filed 14 Feb 2023.